NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 55 min ago
Notice of Information: National Institute on Minority Health and Health Disparities (NIMHD) Award to Morehouse School of Medicine Due to Congressional Earmark
Notice NOT-MD-22-024 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
Funding Opportunity PAR-22-222 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.
Categories: Job Watch, Literature Watch
Notice of Correction to PAR-22-188, NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
Notice NOT-CA-22-119 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to PAR-22-187, NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Notice NOT-CA-22-118 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to NIAMS Acceptance of Diversity Supplement and Re-Entry Supplement Applications
Notice NOT-AR-22-024 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction for RFA-OD-22-015: Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
Notice NOT-OD-22-187 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NINR Participation in PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Notice NOT-NR-22-016 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to the title of PAR-22-181, "NIDA, NIMH, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)"
Notice NOT-NS-22-111 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-23-016 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit developmental/exploratory research to better understand the biology, natural history, and directionality of oral complications associated with pharmacotherapies used to treat opioid use disorders (OUDs). Further, this FOA will support research to explore access to care and other challenges that may contribute to dental and oral disease onset and progression in people with OUD.
Categories: Job Watch, Literature Watch
HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-23-015 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research to better understand the biology, natural history, and directionality of oral complications associated with pharmacotherapies used to treat opioid use disorders (OUDs). Further, this FOA will support research to address access to care and other challenges that may contribute to dental and oral disease onset and progression in people with OUD, with a long-term goal of developing targeted preventive strategies for these individuals.
Categories: Job Watch, Literature Watch
NICHD Global Network for Womens and Childrens Health Research: Data Coordinating Center (U24 Clinical Trial Optional)
Funding Opportunity RFA-HD-23-009 from the NIH Guide for Grants and Contracts. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions to submit applications to participate in the Global Network for Womens and Childrens Health Researchs Data Coordinating Center. The Data Coordinating Center will work with Research Units of U.S.-based research centers partnering with institutions in low-income countries to conduct multi-center observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-poor settings to address the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality. This Funding Opportunity Announcement (FOA) invites applications for a Global Network Data Coordinating Center; a separate FOA invites applications for Global Network Research Units.
Categories: Job Watch, Literature Watch
NICHD Global Network for Womens and Childrens Health Research: Research Units (UG1 Clinical Trial Optional)
Funding Opportunity RFA-HD-23-008 from the NIH Guide for Grants and Contracts. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions in partnership with research centers in low-income countries to submit applications as Research Units (RUs) to participate in the Global Network for Womens and Childrens Health Research. RUs will consist of U.S.-based research centers applying as defined by the World Bank. The RU grantees will become part of a cooperative network in scientific partnership with the NIH to conduct multi-center observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-poor settings to address the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality. This Funding Opportunity Announcement (FOA) invites applications for Global Network Research Units; a separate FOA invites applications for a Global Network Data Coordinating Center.
Categories: Job Watch, Literature Watch
Adjustments to NIH and AHRQ Grant Application Due Dates Between September 22 and September 30, 2022
Notice NOT-OD-22-190 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
Funding Opportunity RFA-DA-23-054 from the NIH Guide for Grants and Contracts. This RFA will act as a parent RFA for the HEAL initiative Translation to Practice Team, specifically encouraging translational dissemination and implementation research focused on addressing overdose deaths and the intersection of pain and OUD. This RFA will function in tandem with targeted NOSIs that announce more specific areas of focus. For FY23, this currently includes the Workforce NOSI (formerly an RFA) and the Violence and Trauma NOSI (also formerly an RFA). It has a companion R61/R33 RFA and is expected to run for 2 years (FY23 and FY24)
Categories: Job Watch, Literature Watch
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
Funding Opportunity RFA-DA-23-053 from the NIH Guide for Grants and Contracts. This RFA will act as a parent RFA for the HEAL initiative Translation to Practice Team, specifically encouraging translational dissemination and implementation research focused on addressing overdose deaths and the intersection of pain and OUD. This RFA will function in tandem with targeted NOSIs that announce more specific areas of focus. For FY23, this currently includes the Workforce NOSI (formerly an RFA) and the Violence and Trauma NOSI (also formerly an RFA). It has a companion R33 RFA and is expected to run for 2 years (FY23 and FY24).
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech
Notice NOT-NS-23-002 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence
Notice NOT-DA-23-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes
Notice NOT-DA-23-008 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
Notice NOT-CA-22-091 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Award Conditions for NOT-NS-23-001: "Notice of Special Interest (NOSI): COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs"
Notice NOT-NS-23-020 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch